Unknown

Dataset Information

0

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.


ABSTRACT: Several different approaches are available to clinicians for determining prostate cancer (PCa) risk. The clinical validity of various PCa risk assessment methods utilizing single nucleotide polymorphisms (SNPs) has been established; however, these SNP-based methods have not been compared. The objective of this study was to compare the three most commonly used SNP-based methods for PCa risk assessment. Participants were men (n = 1654) enrolled in a prospective study of PCa development. Genotypes of 59 PCa risk-associated SNPs were available in this cohort. Three methods of calculating SNP-based genetic risk scores (GRSs) were used for the evaluation of individual disease risk such as risk allele count (GRS-RAC), weighted risk allele count (GRS-wRAC), and population-standardized genetic risk score (GRS-PS). Mean GRSs were calculated, and performances were compared using area under the receiver operating characteristic curve (AUC) and positive predictive value (PPV). All SNP-based methods were found to be independently associated with PCa (all P < 0.05; hence their clinical validity). The mean GRSs in men with or without PCa using GRS-RAC were 55.15 and 53.46, respectively, using GRS-wRAC were 7.42 and 6.97, respectively, and using GRS-PS were 1.12 and 0.84, respectively (all P < 0.05 for differences between patients with or without PCa). All three SNP-based methods performed similarly in discriminating PCa from non-PCa based on AUC and in predicting PCa risk based on PPV (all P > 0.05 for comparisons between the three methods), and all three SNP-based methods had a significantly higher AUC than family history (all P < 0.05). Results from this study suggest that while the three most commonly used SNP-based methods performed similarly in discriminating PCa from non-PCa at the population level, GRS-PS is the method of choice for risk assessment at the individual level because its value (where 1.0 represents average population risk) can be easily interpreted regardless of the number of risk-associated SNPs used in the calculation.

SUBMITTER: Conran CA 

PROVIDER: S-EPMC4955173 | biostudies-literature | 2016 Jul-Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.

Conran Carly A CA   Na Rong R   Chen Haitao H   Jiang Deke D   Lin Xiaoling X   Zheng S Lilly SL   Brendler Charles B CB   Xu Jianfeng J  

Asian journal of andrology 20160701 4


Several different approaches are available to clinicians for determining prostate cancer (PCa) risk. The clinical validity of various PCa risk assessment methods utilizing single nucleotide polymorphisms (SNPs) has been established; however, these SNP-based methods have not been compared. The objective of this study was to compare the three most commonly used SNP-based methods for PCa risk assessment. Participants were men (n = 1654) enrolled in a prospective study of PCa development. Genotypes  ...[more]

Similar Datasets

| S-EPMC6773522 | biostudies-literature
| S-EPMC5546451 | biostudies-literature
| S-EPMC5437948 | biostudies-literature
| S-EPMC7483627 | biostudies-literature
| S-EPMC6765008 | biostudies-literature
| S-EPMC7340536 | biostudies-literature
| S-EPMC8389650 | biostudies-literature
| S-EPMC4112479 | biostudies-literature
| S-EPMC6639207 | biostudies-literature
| S-EPMC8066654 | biostudies-literature